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Laparoscopic pancreaticoduodenectomy has proven to be a safe and effective alternative to open pancreati-
coduodenectomy with similar oncologic outcomes. Cases including excision of the hepatic artery with or 
without reconstruction during pancreaticoduodenectomy have been reported for periampullary cancer. 
Here we present a case of an 82-year-old patient who underwent laparoscopic pancreaticoduodenectomy 
following preoperative arterial embolization of an aberrant right hepatic artery arising from the superior 
mesenteric artery.
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CASE REPORT
INTRODUCTION
Although still debated, the literature and current practices show 
that laparoscopic pancreaticoduodenectomy (LPD) is feasible, 
safe, and even oncologically effective in managing periampul-
lary cancer. A recent meta-analysis comparing open pancreatico-
duodenectomy (PD) and LPD demonstrated that LPD is as safe 
and effective as open PD, with similar perioperative and long-
term oncologic outcomes [1], and with shorter hospital stay, less 
intraoperative bleeding, and fewer postoperative complications. 
In addition, a randomized control study also demonstrated that 
LPD was associated with a shorter length of hospital stay and a 
more favorable postoperative course with similar oncologic out-
comes [2].
It has also been suggested that LPD with venous vascular re-
section is feasible and safe with comparable perioperative results 
[3]. However, there is a demand for advanced surgical techniques 
and experience to prevent unexpected intraoperative accidents. 
Therefore, standardization remains difficult, and this plays a role 
in limiting the indication for LPD. There are currently no reports 
of LPD with combined hepatic artery resection and reconstruc-
tion, suggesting that this clinical situation is one of the technical 
limitations in expanding the indication for LPD.
Hepatic perfusion is crucial during LPD, and some studies 
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even suggest that there is potential collateral hepatic f low after 
division of the proper hepatic artery [4]. Hepatic collateral f low 
depends on the individual vascular anatomical characteristics 
and the duration since the injury. However, in some critical cases, 
collateral f low develops through the liver suspensory ligaments 
and small retroperitoneal vessels, which take time to develop 
sufficient hepatic perfusion to avoid hepatic necrosis, especially 
after PD. This intraoperative insult may worsen postoperative 
recovery after PD.
In this report, we present the case of an 82-year-old female pa-
tient who successfully underwent LPD with excision of the right 
hepatic artery following preoperative short segment emboliza-
tion for mid-bile duct cancer. 
CASE REPORT
Case presentation 
An 82-year-old woman was admitted to our hospital with gen-
eral weakness, abdominal pain, and fever in March 2020. The 
patient’s general appearance was good and her vital signs were 
within normal limits, with the exception of a fever of 39.3°C. The 
patient had a history of hypertension, old cerebral infarction, and 
nontuberculous mycobacterial pneumonia.
Laboratory findings showed a complete blood count with a 
shift to left (neutrophil, 92%; reference, 39%–74%), elevated liver 
profile including aspartate transaminase (2,616 IU/L; reference, 
13–34 IU/L), alanine transaminase (499 IU/L; reference, 5–46 IU/
L), elevated total bilirubin (3.2 mg/dL; reference, 0.4–1.5 mg/dL), 
direct bilirubin (1.8 mg/dL; reference, 0.1–0.4 mg/dL), alkaline 
phosphatase (396 IU/L; reference, 50–155 IU/L), and gamma-glu-
tamyl transpeptidase (347 IU/L; reference, 7–35 IU/L). The initial 
serum carbohydrate antigen 19-9 (CA 19-9) level was 143 U/mL 
(reference, 0.0–34 U/mL), which increased to 2,308 U/mL during 
the preoperative evaluation period. 
Abdominal magnetic resonance imaging showed dif fuse 
bile duct dilatation with a distended gallbladder resulting from 
an occlusive mass effect in the suprapancreatic common bile 
duct (CBD) area. In addition, the tumor seemed to be abutting 
the portal vein, and there was an aberrant right hepatic artery 
(aRHA) rising from the superior mesenteric artery (SMA) in the 
computed tomography (CT) scan (Fig. 1A). Positron emission 
tomography-CT scans showed not only intense f luorodeoxyglu-
cose uptake in the hepatoduodenal ligament area but also intense 
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Fig. 1. Preoperative evaluation. (A) 
Common bile duct cancer abutting to 
the portal vein and right aberrant hepatic 
artery (green arrows). (B) Paraaortic 
lymph node with considerable fluoro-
deoxyglucose uptake was noted to be 
suspicious metastatic lymph node (thick 
white arrow). (C) Preoperative angiog-
raphy and segmental embolization of 
aberrant right hepatic artery (aRHA) were 
performed. (D) Subsequent celiac angio-
gram demonstrated the well perfusion of 
the right liver (black arrows) through the 
left hepatic artery even after occlusion of 
aRHA.
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signals in the paraaortic areas (Fig. 1B). No other evidence of 
systemic metastasis was observed. Subsequent endoscopic ret-
rograde cholangiopancreatography with biopsy and endoscopic 
retrograde biliary drainage catheter insertion was performed, 
and the biopsy indicated a well-differentiated adenocarcinoma. 
Her general condition and preoperative evaluation allowed her 
to be considered as a candidate for PD with combined excision of 
aRHA and paraaortic lymph node clearance.
Preoperative celiac and superior mesentery artery 
angiography with embolization of the aberrant right 
hepatic artery 
Angiography was performed on March 3, 2020, to confirm the 
aRHA from the SMA and the left hepatic artery, with collateral 
f low to the right liver from the celiac artery (Fig. 1C). Subsequent 
embolization of the aRHA was performed to further increase 
the potential collateral blood f low in case of combined excision 
of the involved aRHA during the surgical procedure (Fig. 1D). A 
follow-up CT scan 10 days later revealed that there was no isch-
emic change to the right liver after embolization of the aRHA, 
which was evidence of sufficient collateral blood f low. 
Operation 
On March 27, 2020, 2 weeks after the embolization, the patient 
underwent laparoscopic PD with tangential resection of the 
portal vein and combined excision of the aRHA. Some enlarged 
lymph nodes stationed around the celiac trunk and in the ret-
roperitoneum were sent for frozen sectioning, all of which were 
found to be free from carcinoma. Intraoperative paraaortic 
lymph node sampling was performed, and the frozen sections 
were reported to be free from carcinoma (Fig. 2A). Following 
confirmation that there were no metastatic distant lymph nodes, 
the surgical procedure continued, and the origin of the aRHA 
was ligated using vascular Endo GIA (Medtronic, Minneapolis, 
MN, USA) (Fig. 2B). The upper resection margin of the bile duct 
was sent for frozen sectioning, and no cancer involvement was 
reported. A small part of the portal vein was adhered to the 
tumor and could not be separated. Tangential vascular partial 
resection was performed, and primary repair was performed 
using a 5-0 monofilament non-absorbable suture after portal 
Fig. 2. Operative view. (A) Paraaortic lymph node sampling and frozen-section biopsy. (B) Division of the origin of aberrant right hepatic artery (asterisk) 
by Endo GIA (Medtronic, Minneapolis, MN, USA). (C) Tangential resection of the portal vein (PV) after bulldog vascular clamp (long thin white arrows). (D) 
Final surgical field resection phase of pancreaticoduodenectomy. Note the divided distal portion of aberrant right hepatic artery (thick white arrows), and 
primary repair site of the resected PV (long thin white arrows). D, duodenum; LRV, left renal vein; IVC, inferior renal vein; Ao, aorta; P-M, pancreatic cut 
surface; P, remnant pancreas; Rp-M, retroperitoneal or superior mesenteric artery lateral margin area; BD, resected bile duct; LHA, left hepatic artery; 

















LPD with excision of aRHA after segmental embolization
www.e-jmis.org
107
vein cross-clamping with two bull-dog clamps (Fig. 2C). Upon 
completion of the resection phase (Fig. 2D), subsequent pancre-
atojejunostomy and hepaticojejunostomy were performed in the 
usual manner. The surgery took 450 minutes and there was 250 
mL of blood loss.
Postoperative course and pathological examination 
The patient recovered without significant surgery-related com-
plications. Clinically, nonrelevant postoperative pancreatic fis-
tula (biochemical leak) was noted, and all of the surgical drains 
were removed on postoperative day 5. The serum CA 19-9 level 
was 165 U/mL on postoperative day 7. Postoperative conserva-
tive management including nutritional support was necessary 
to improve the patient’s general condition, and she was finally 
discharged on postoperative day 24. The patient visited the out-
patient department for an 8-month follow-up after surgery on 
November 23, 2020. She was in good general condition with labo-
ratory results within normal range and her CT scan showed no 
evidence of recurrence. 
Final pathological examination revealed that the tumor was a 
2.3-cm sized adenocarcinoma (moderately differentiated) of the 
CBD. The tumor invaded the bile duct wall and periductal fat 
tissue at a depth of 7 mm (pathologic T2), but no extension to the 
pancreas was found. Lymphovascular invasion was absent, but 
perineural invasion was noted. Fortunately, the resected portal 
vein and right hepatic artery were found to be free from cancer. 
It was noted that none of the resection margins, including the 
CBD, pancreatic duct, retroperitoneal SMA lateral margin, supe-
rior mesenteric vein-portal vein groove, anterior surface, posteri-
or surface, and the duodenum, were invaded by malignant cells. 
No metastatic lymph nodes were identified.
DISCUSSION
Margin-negative resection is very important in the treatment of 
bile duct cancer. In this case, PD was considered curative treat-
ment for the patient. Considering the patient’s age, segmental 
resection of the bile duct could have been an alternative to PD. 
However, the intraoperative distal margin of the resected bile 
duct based on frozen-section biopsy during the operation might 
have resulted in subsequent PD and prolongation of the opera-
tion, which could have negatively impacted the patient’s recov-
ery. In addition, a recent Korea-Japan international collaboration 
study [5] showed impaired long-term oncologic outcomes of seg-
mental resection of the bile duct when compared with PD for the 
treatment of mid-bile duct cancer. Although the current report 
is not a randomized control study, it provides important insight 
into surgical decision-making for mid-bile duct cancer.
Although laparoscopic PD is controversial, the accumulation 
of experience demonstrates that LPD is safe and effective, show-
ing improved perioperative surgical outcomes with comparable 
long-term oncologic outcomes. Therefore, well-selected patients 
can gain clinical benefit from LPD in clinical oncology. In ad-
dition, recent literature also suggests that LPD is appropriate 
for the treatment of the elderly [6]. Generally, age itself is not a 
contraindication for PD, and functional performance status is 
considered more important in patient selection. Therefore, care-
ful patient selection is required when offering surgery to this age 
group. From the viewpoint of the current aged society, this issue 
will be discussed further in the near future. 
The oncologic impact of combined hepatic arterial resection 
in the treatment of bile duct cancer remains controversial. How-
ever, several studies have shown favorable long-term oncologic 
outcomes, suggesting the oncologic role of aggressive surgery in 
treating advanced bile duct cancer [7]. Although aRHA can be 
safely resected during PD, there were several reasons for choosing 
preoperative embolization of aRHA for the current patient. First, 
laparoscopic dissection of the aRHA from the abutting tumor 
would result in a long operation time, which could negatively 
impact the recovery of this patient. Second, there was a potential 
risk of postoperative hemorrhage from the dissected aRHA as a 
result of arterial denuding during the surgical procedure. Third, 
laparoscopic arterial reconstruction (end-to-end) is considered 
technically difficult and unstable. Therefore, combined excision 
of the aRHA was initially planned for procedural safety, simplic-
ity, and curability. Lastly, preoperative angiogram demonstrated 
sufficient collateral vessels to the right liver, and as such, com-
bined excision of the aRHA could have been feasible without 
preoperative arterial embolization. However, ischemic hepatic 
damage during the operation could have resulted in dismal re-
covery after surgery in this octogenarian patient. A potential 
reservoir of collateral blood f low to the right liver was expected 
to be further developed after embolization of aRHA. Therefore, 
taking all of this into consideration, preoperative embolization of 
the aRHA followed by LPD was decided to enhance the proce-
dural safety for this patient.
Aside from the current report, we also consider the situation in 
which the distal bile duct cancer is invading the common hepatic 
artery or the proper hepatic artery? Is this a contraindication for 
surgical resection? Although neoadjuvant chemotherapy is wide-
ly accepted in borderline and locally advanced pancreatic cancer 
[8], there is still a lack of evidence to support neoadjuvant chemo-
therapy followed by aggressive surgical extirpation in advanced 
bile duct cancer [9]. We consider that this preoperative arterial 
embolization may function to enhance the hepatic collateral f low 
may work such that an aggressive surgical approach with com-
bined hepatic arterial resection can be performed selectively [4]. 
Therefore, the present case demonstrates the safety and technical 
feasibility of LPD with hepatic arterial excision after preopera-
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tive hepatic artery embolization in well-selected advanced bile 
duct cancer. Cloyd et al. [10] first reported preoperative emboliza-
tion of a tumor encasing the right hepatic artery in patients with 
PD; however, to the best of our knowledge, the present case is the 
first published report in the field of LPD.
In summary, in specif ic cases where the hepatic artery is 
invaded by periampullary cancer, LPD with excision of the in-
volved hepatic artery without reconstruction is both safe and 
feasible. However, patient selection is key in order to reduce 
perioperative risk and ensure safety after hepatic artery excision. 
Therefore, preoperative short segment embolization may be a po-
tential approach to allow safe LPD with hepatic artery excision. 
Further experiences should follow.
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